Birchtech vs ClearSign Technologies
BCHT and CLIR side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BCHT and CLIR compare
Birchtech is the larger company, worth 1.8 times as much as ClearSign Technologies ($28.9M against $16.2M).
ClearSign Technologies grew revenue faster over the last twelve months (82.7% versus 11.0% for Birchtech).
ClearSign Technologies scores higher on the StockData Score (9 against 7 for Birchtech), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BCHT | CLIR |
|---|---|---|
| Size and price | ||
| Market cap | $28.9M | $16.2M |
| Share price | $1.10 | $2.38 |
| Change, 1 year | −68.6% | −74.3% |
| Change, 5 years | −71.8% | −87.7% |
| Beta (5Y) | 0.62 | 1.66 |
| Employees | 20 | 15 |
| StockData Score | ||
| Total score | 7 | 9 (better) |
| Valuation score | 2 (better) | 1 |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 4 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.5× (better) | 3.0× |
| P/B | 3.5× | – |
| FCF yield | −13.3% | – |
| Fair value | $1.97 | – |
| Margin of safety | 44.3% | – |
| Growth | ||
| Revenue growth (TTM) | 11.0% | 82.7% (better) |
| Revenue growth, 5Y average | 16.7% | – |
| Profitability | ||
| Gross margin | 39.7% (better) | 18.5% |
| Operating margin | −17.1% (better) | −117% |
| Net margin | – | −96.1% |
| FCF margin | −20.1% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | −240.4× | – |
| Current ratio | 1.42 | 4.78 (better) |
| Altman Z-score | −3.52 (better) | −8.68 |
| Piotroski F-score | 5 (better) | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 17.3% | 6.9% |
| Held by insiders | 65.4% | 64.4% |
| Insider net buying, 12 months | $750K | $1.8M (better) |
| Short interest, % of float | 0.38% | 0.41% |
Go deeper
- BCHT stock overview
- BCHT income statement
- BCHT valuation and score
- CLIR stock overview
- CLIR income statement
- CLIR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.